NPS PHARMACEUTICALS INC Contracts & Agreements

AGREEMENT AND PLAN OF MERGER dated as of JANUARY 11, 2015 among NPS PHARMACEUTICALS, INC., SHIRE PHARMACEUTICAL HOLDINGS IRELAND LIMITED, KNIGHT NEWCO 2, INC. and SHIRE PLC... (Filed With SEC on January 12, 2015)

NPS PHARMACEUTICALS, INC. CHANGE IN CONTROL SEVERANCE PAY PLAN AS AMENDED THROUGH JANUARY 11, 2015 (Filed With SEC on January 12, 2015)

First Amendment to Development and Supply Agreement, effective as of May 14, 2014, by and between Hospira Worldwide, Inc. and the Company (Filed With SEC on November 10, 2014)

Employment Agreement with Christine Mikail (Filed With SEC on May 8, 2014)

Offer Letter with Robin Friedman (Filed With SEC on May 8, 2014)

Employment Agreement with Paul Firuta (Filed With SEC on May 8, 2014)

Amended and Restated Employment Agreement with Eric Pauwels (Filed With SEC on May 8, 2014)

NPS PHARMACEUTICALS, INC. 2014 OMNIBUS EQUITY COMPENSATION PLAN (Filed With SEC on May 7, 2014)

NPS PHARMACEUTICALS, INC. 2014 OMNIBUS EQUITY COMPENSATION PLAN INCENTIVE STOCK OPTION SUMMARY OF AWARD (Filed With SEC on May 7, 2014)

NPS PHARMACEUTICALS, INC. 2014 OMNIBUS EQUITY COMPENSATION PLAN NONQUALIFIED STOCK OPTION SUMMARY OF AWARD (Filed With SEC on May 7, 2014)

NPS PHARMACEUTICALS, INC. 2014 OMNIBUS EQUITY COMPENSATION PLAN RESTRICTED STOCK UNIT SUMMARY OF AWARD (Filed With SEC on May 7, 2014)

NPS PHARMACEUTICALS, INC. DEFERRED COMPENSATION PLAN (Filed With SEC on May 7, 2014)

NPS PHARMACEUTICALS, INC. 6,000,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on May 22, 2013)

2005 Omnibus Incentive Plan NPS Pharmaceuticals, Inc. As amended through May 7, 2013 (subject to stockholder approval) (Filed With SEC on May 9, 2013)

TERMINATION AND TRANSITION AGREEMENT DATED AS OF MARCH 18, 2013 BY AND AMONG NPS PHARMACEUTICALS, INC., TAKEDA GmbH, AND TAKEDA PHARMA A/S (Filed With SEC on March 19, 2013)

2005 Omnibus Incentive Plan NPS Pharmaceuticals, Inc. As amended through May 7, 2013 (subject to stockholder approval) (Filed With SEC on February 13, 2013)

NPS Pharmaceuticals Inc. Stock Option Grant Agreement (Filed With SEC on February 13, 2013)

NPS Pharmaceuticals Inc. Restricted Stock Unit Agreement Name: [[FIRSTNAME]] [[LASTNAME]] Award Number: [[GRANTNUMBER]] Grant Date: [[GRANTDATE]] Plan: [[STOCKOPTIONPLANNAME]]... (Filed With SEC on February 13, 2013)

Change in Control Severance Pay Plan, as amended on August 20, 2012 (Filed With SEC on November 9, 2012)

Commercial Manufacturing Agreement dated as of December 21, 2009, by and between the Registrant and Vetter Pharma International GmbH (Filed With SEC on November 9, 2012)

Employment Agreement with Glenn Melrose (Filed With SEC on November 9, 2012)

Commercial Manufacturing Agreement dated as of December 21, 2009, by and between the Registrant and Vetter Pharma International GmbH PDF (Filed With SEC on November 9, 2012)

Employment Agreement with Glenn Melrose PDF (Filed With SEC on November 9, 2012)

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer PDF (Filed With SEC on November 9, 2012)

Fifth Amendment to the Development and License Agreement between the Registrant and Amgen Inc. dated June 29, 2012 (Filed With SEC on August 1, 2012)

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer PDF (Filed With SEC on August 1, 2012)

Nonemployee Director Compensation Program (Filed With SEC on May 3, 2012)

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer PDF (Filed With SEC on May 3, 2012)

Employment Agreement with Eric Pauwels (Filed With SEC on November 3, 2011)

Exclusive Patent License Agreement between the Registrant and GlaxoSmithKline LLC dated July 29, 2011 (Filed With SEC on November 3, 2011)

First Amendment to the Development and License Agreement between the Registrant and Amgen Inc. dated November 19, 2004 (Filed With SEC on November 3, 2011)

Second Amendment to the Development and License Agreement between the Registrant and Amgen Inc. dated November 19, 2004 (Filed With SEC on November 3, 2011)

Third Amendment to the Development and License Agreement between the Registrant and Amgen Inc. dated March 4, 2008 (Filed With SEC on November 3, 2011)

Manufacturing Agreement between Registrant and SynCo Bio Partners B.V. dated August 1, 2009 (Filed With SEC on November 3, 2011)

Exclusive Patent License Agreement between the Registrant and GlaxoSmithKline LLC dated July 29, 2011 PDF (Filed With SEC on November 3, 2011)

First Amendment to the Development and License Agreement between the Registrant and Amgen Inc. dated November 19, 2004 PDF (Filed With SEC on November 3, 2011)

Second Amendment to the Development and License Agreement between the Registrant and Amgen Inc. dated November 19, 2004 PDF (Filed With SEC on November 3, 2011)

Third Amendment to the Development and License Agreement between the Registrant and Amgen Inc. dated March 4, 2008 PDF (Filed With SEC on November 3, 2011)

Fourth Amendment to the Development and License Agreement between the Registrant and Amgen Inc. dated August 10, 2011 (Filed With SEC on November 3, 2011)

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer PDF (Filed With SEC on November 3, 2011)

FOURTH AMENDMENT TO DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on August 15, 2011)

2005 Omnibus Incentive Plan NPS Pharmaceuticals, Inc. As amended through May 18, 2011 (Filed With SEC on May 24, 2011)

NPS Pharmaceuticals, Inc. 11,000,000 Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on April 14, 2011)

6,880,000Shares NPSPharmaceuticals, Inc. CommonStock UNDERWRITINGAGREEMENT (Filed With SEC on September 16, 2010)

NPSP PHARMACEUTICALS, INC. 2010 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 24, 2010)

NPS PHARMACEUTICALS, INC. 9,000,000 Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on April 16, 2010)

Agreement for Sale and Assignment of Rights, dated February 26, 2010, between NPS Pharmaceuticals, Inc. and LSRC II S.R.L (Filed With SEC on March 11, 2010)

PDF provided as courtesy (Filed With SEC on March 11, 2010)

COMMONSTOCK PURCHASE AGREEMENT Dated August 5, 2009 by and between NPSPHARMACEUTICALS, INC. and AZIMUTHOPPORTUNITY LTD. (Filed With SEC on August 6, 2009)

2005 Omnibus Incentive Plan NPS Pharmaceuticals, Inc. As amended on May 14, 2009 (Filed With SEC on May 18, 2009)

Form of Performance-Based Stock Option Agreement under the NPS Pharmaceutical, Inc. 1998 Stock Option Plan (Filed With SEC on March 16, 2009)

Change in Control Severance Pay Plan, as amended (Filed With SEC on March 16, 2009)

First Amendment to the Employment Agreement with Francois Nader (Filed With SEC on March 16, 2009)

Second Amendment to the Employment Agreement with Francois Nader (Filed With SEC on March 16, 2009)

Employment Agreement with Roger Garceau (Filed With SEC on March 16, 2009)

PDF provided as courtesy (Filed With SEC on March 16, 2009)

NPS PHARMACEUTICALS, INC. (Filed With SEC on May 28, 2008)

Employment Agreement with Francois Nader (Filed With SEC on May 19, 2008)

First Amendment to Restrictive Covenant Agreement with Francois Nader (Filed With SEC on May 19, 2008)

First Amendment to Restrictive Covenant Agreement with Francois Nader PDF (Filed With SEC on May 19, 2008)

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer PDF (Filed With SEC on May 19, 2008)

LICENSE AGREEMENT (Filed With SEC on November 9, 2007)

AGREEMENT FOR SALE AND ASSIGNMENT OF RIGHTS NPS PHARMACEUTICALS, INC., NPS ALLELIX CORP. (Filed With SEC on November 9, 2007)

DISTRIBUTION AND LICENSE AGREEMENT BY AND BETWEEN NPS ALLELIX CORP. (Filed With SEC on November 9, 2007)

AMENDMENT AGREEMENT TO DISTRIBUTION AND LICENSE AGREEMENT DATED SEPTEMBER 24, 2007 BY AND BETWEEN (Filed With SEC on November 9, 2007)

LICENSE AGREEMENT THIS AGREEMENT, effective September 28, 1995, is entered into - BY - (Filed With SEC on November 9, 2007)

SECOND SUPPLEMENTAL INDENTURE dated as of October 20, 2006 by and between CINACALCET ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes, (Filed With SEC on August 31, 2007)

THIRD SUPPLEMENTAL INDENTURE dated as of July 9, 2007 by and between CINACALCET ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes, (Filed With SEC on August 31, 2007)

FOURTH SUPPLEMENTAL INDENTURE dated as of August 1, 2007 by and between CINACALCET ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes, (Filed With SEC on August 31, 2007)

FIFTH SUPPLEMENTAL INDENTURE dated as of August 7, 2007 (Filed With SEC on August 31, 2007)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 31, 2007)

[FORM OF CONVERTIBLE NOTE] (Filed With SEC on August 31, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 31, 2007)

SUBLEASE (Filed With SEC on August 7, 2007)

PURCHASE AND SALE AGREEMENT (383 Colorow Drive) (Filed With SEC on August 7, 2007)

AGREEMENT OF PURCHASE AND SALE (383 Colorow Drive, Salt Lake City, Utah) (Filed With SEC on May 9, 2007)

AGREEMENT OF PURCHASE AND SALE (Filed With SEC on May 9, 2007)

AMENDMENT AGREEMENT (Filed With SEC on March 14, 2007)

SEPARATION AGREEMENT (Filed With SEC on March 14, 2007)

SEPARATION AGREEMENT (Filed With SEC on August 3, 2006)

EMPLOYMENT AGREEMENT (Filed With SEC on March 3, 2006)

AGREEMENT OF PURCHASE AND SALE (Filed With SEC on March 3, 2006)

LEASE AGREEMENT (383 Colorow Drive, Salt Lake City, Utah) (Filed With SEC on March 3, 2006)

7,000,000 Shares (Filed With SEC on September 13, 2005)

STOCKOPTION GRANT AGREEMENT UNDER THE (Filed With SEC on July 26, 2005)

DEFERREDSTOCK UNIT AWARD AGREEMENT pursuant to the (Filed With SEC on July 1, 2005)

INDENTURE (Filed With SEC on February 7, 2005)

INDENTURE (Filed With SEC on December 23, 2004)

DISTRIBUTION AND LICENSE AGREEMENT Between NPS ALLELIXCORP. And (Filed With SEC on August 9, 2004)

FIRST AMENDMENT TO DISTRIBUTION ANDLICENSE AGREEMENT (Filed With SEC on August 9, 2004)

EXTENSION AND ADDITIONAL SPACE AGREEMENT (Filed With SEC on August 9, 2004)

LEASE AGREEMENT (Filed With SEC on August 9, 2004)

NPS PHARMACEUTICALS, INC. (Filed With SEC on February 10, 2004)

NPS PHARMACEUTICALS, INC. 1998 STOCK OPTION PLAN (reflects all amendments by the Board of Directors through June 2003) (Filed With SEC on February 10, 2004)

AGREEMENT PROVIDING SPECIFIED BENEFITS (Filed With SEC on February 10, 2004)

UNIVERSITY OF UTAH RESEARCH PARK MASTER FORM LEASE LEASE AGREEMENT (Filed With SEC on February 10, 2004)

W I T N E S S ET H: (Filed With SEC on February 10, 2004)

TERM SHEET (Filed With SEC on February 10, 2004)

NPS PHARMACEUTICALS, INC. To U.S. Bank National Association, as Trustee INDENTURE Dated as of June 17, 2003 3% Convertible Notes Due 2008 CROSS REFERENCE TABLE* (Filed With SEC on August 12, 2003)

REGISTRATION RIGHTS AGREEMENT among NPS PHARMACEUTICALS,INC. as Issuer, and MORGAN STANLEY & CO. INCORPORATED and GOLDMAN, SACHS &CO., as Initial Purchasers Dated as of June 17,... (Filed With SEC on August 12, 2003)

NPS PHARMACEUTICALS, INC. 1987 STOCK OPTION PLAN (reflects all amendments by the Board of Directors through September 2002) (Filed With SEC on March 21, 2003)

NPS PHARMACEUTICALS, INC. 1994 EQUITY INCENTIVE PLAN (reflects all amendments by the Board of Directors through December 2002) (Filed With SEC on March 21, 2003)

NPS PHARMACEUTICALS, INC. 1994 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN (as Amended by the Board of Directors on December 2002) (Filed With SEC on March 21, 2003)

NPS PHARMACEUTICALS, INC. 1994 EMPLOYEE STOCK PURCHASE PLAN (as Amended by the Board of Directors on December 2002) (Filed With SEC on March 21, 2003)

NPS PHARMACEUTICALS, INC. 1998 STOCK OPTION PLAN (reflects all amendments by the Board of Directors through December 2002) (Filed With SEC on March 21, 2003)

NPS Pharmaceuticals, Inc. SEVERANCE PAY PLAN (Filed With SEC on March 21, 2003)

One Franklin Plaza, PO Box 7929, Philadelphia, PA 19101.Telephone ###-###-####. Fax ###-###-####. (Filed With SEC on March 21, 2003)

Page 1 (Filed With SEC on March 21, 2003)

1999 Patent Agreement Amendment between THE BRIGHAM AND WOMENS HOSPITAL, INC. and NPS PHARMACEUTICALS, INC. (Filed With SEC on March 21, 2003)

AMENDMENT TO LEASE EXPANSION (Filed With SEC on March 21, 2003)

THIRD AMENDMENT TO LEASE EXPANSION (Filed With SEC on March 21, 2003)

Exhibit 10.12E FOURTH AMENDMENT TO LEASE (Filed With SEC on March 21, 2003)

AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG NPS PHARMACEUTICALS, INC. ENZON PHARMACEUTICALS, INC. MOMENTUM MERGER CORPORATION NEWTON ACQUISITION CORPORATION AND... (Filed With SEC on February 21, 2003)

4,000,000 Shares NPS PHARMACEUTICALS, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on October 29, 2002)

Category

Industry

Companies

Contracts

NPS PHARMACEUTICALS INC Contracts & Agreements